A detailed history of Rtw Investments, LP transactions in Gh Research PLC stock. As of the latest transaction made, Rtw Investments, LP holds 5,499,769 shares of GHRS stock, worth $68.5 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
5,499,769
Previous 3,327,129 65.3%
Holding current value
$68.5 Million
Previous $23.3 Million 160.47%
% of portfolio
0.99%
Previous 0.38%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$7.91 - $17.99 $17.2 Million - $39.1 Million
2,172,640 Added 65.3%
5,499,769 $60.7 Million
Q3 2023

Nov 14, 2023

BUY
$9.8 - $14.15 $11.4 Million - $16.4 Million
1,158,172 Added 53.4%
3,327,129 $33.4 Million
Q2 2021

Aug 13, 2021

BUY
$19.25 - $21.73 $41.8 Million - $47.1 Million
2,168,957 New
2,168,957 $42.7 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $648M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.